BridgeMD
New treatment option for Posterior Vitreous Detachment
Official title YAG Laser Vitreolysis for Vitreous Floaters
ClinicalTrials.gov ID: NCT06915922
What this study is testing
- What it's testing
- The purpose of this study is to measure how the quality of life, the structure of eye, and vision change after treatment for the opacities in the gel (vitreous) that fills the center of eye which cause vision disturbances commonly called "floaters". In this study the vitreous floaters are treated using a Neodymium-doped yttrium-aluminum-garnet (Nd:YAG) laser.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Only one eye per patient will be included in this study
- Able and willing to give informed consent
- Age ≥18 years
- Suffering from symptomatic vitreous floaters
- Floaters arising from either/both:
You likely can't join if
- Patient presenting with vitreous opacities outside of the described safety area (within 3mm of the retina or 6mm from the lens)
- Have clinically significant cataract (lens opacification) in one or both eyes which are in the opinion of the examining doctor more significant in...
- Present with untreated retinal tears or retinal holes requiring treatment at the discretion of the study investigator
- Have high risk of peripheral lesions requiring treatment at the discretion of the study investigator
- Have synchysis scintillans (unusual vitreous opacities from old blood)
- Have asteroid hyalosis (unusual vitreous opacities from cholesterol)
See the full eligibility criteria
- Only one eye per patient will be included in this study
- Able and willing to give informed consent
- Age ≥18 years
- Suffering from symptomatic vitreous floaters
- Floaters arising from either/both:
- myopic vitreopathy
- posterior vitreous detachment
- Floaters meeting the following characteristics:
- Present for ≥3 months
- One single or more dense and well-defined vitreous opacities,
- A Weiss Ring or opacities which are within the safety area, at least 3mm away from the retina and 6mm away from the lens
- Visible on contact lens biomicroscopy
- Patient presenting with vitreous opacities outside of the described safety area (within 3mm of the retina or 6mm from the lens)
- Have clinically significant cataract (lens opacification) in one or both eyes which are in the opinion of the examining doctor more significant in impacting vision as compared to that caused by vitreous opacities; or...
- Present with untreated retinal tears or retinal holes requiring treatment at the discretion of the study investigator
- Have high risk of peripheral lesions requiring treatment at the discretion of the study investigator
- Have synchysis scintillans (unusual vitreous opacities from old blood)
- Have asteroid hyalosis (unusual vitreous opacities from cholesterol)
- Have vitreous hemorrhage (fresh blood in the center of the eye)
- Have active photopsia (flashing lights)
- History of previous YAG laser vitreolysis treatments, or vitrectomy for any condition (retinal detachment, proliferative diabetic retinopathy, etc.)
- Have Posterior Vitreous Detachment (separation of vitreous away from the retina lining the inside of the back of the eye) within the past 3 months
- Are unable to attend study appointments
- Have any other significant ocular or non-ocular condition that, at the discretion of the study investigator, puts the subject at risk or influences the results of the study
- History of intraocular surgery within 6 months from study entry
- History of retinal laser within 2 months from study entry
The study team makes the final eligibility decision.
Where it's taking place
- Huntington Beach, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Huntington Beach, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.